| Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
|---|
| Pamidronic-acid | hsa00531 | Glycosaminoglycan degradation | 3.53E-02 | 1 | P15586 | GNS | More | | | Pamidronic-acid | hsa01524 | Platinum drug resistance | 2.64E-03 | 3 | P04637, Q14790, P48023 | TP53, CASP8, FASLG | More | | | Pamidronic-acid | hsa04068 | FoxO signaling pathway | 1.02E-02 | 2 | P48023, Q96BR1 | FASLG, SGK3 | More | | | Pamidronic-acid | hsa04115 | p53 signaling pathway | 2.70E-02 | 2 | Q14790, P04637 | CASP8, TP53 | More | | | Pamidronic-acid | hsa04151 | PI3K-Akt signaling pathway | 7.77E-03 | 3 | P48023, P04637, Q96BR1 | FASLG, TP53, SGK3 | More | | | Pamidronic-acid | hsa04210 | Apoptosis | 1.32E-03 | 4 | P04637, Q14790, P48023, P42575 | TP53, CASP8, FASLG, CASP2 | More | | | Pamidronic-acid | hsa04722 | Neurotrophin signaling pathway | 3.06E-02 | 2 | P48023, P04637 | FASLG, TP53 | More | | | Pamidronic-acid | hsa04932 | Non-alcoholic fatty liver disease | 2.70E-02 | 2 | Q14790, P48023 | CASP8, FASLG | More | | | Pamidronic-acid | hsa05142 | Chagas disease | 2.37E-02 | 2 | P48023, Q14790 | FASLG, CASP8 | More | | | Pamidronic-acid | hsa05160 | Hepatitis C | 4.94E-03 | 3 | P04637, P48023, Q14790 | TP53, FASLG, CASP8 | More | | | Pamidronic-acid | hsa05161 | Hepatitis B | 8.19E-03 | 3 | P48023, Q14790, P04637 | FASLG, CASP8, TP53 | More | | | Pamidronic-acid | hsa05162 | Measles | 8.19E-03 | 3 | P48023, P04637, Q14790 | FASLG, TP53, CASP8 | More | | | Pamidronic-acid | hsa05163 | Human cytomegalovirus infection | 1.02E-02 | 3 | P48023, Q14790, P04637 | FASLG, CASP8, TP53 | More | | | Pamidronic-acid | hsa05164 | Influenza A | 4.65E-02 | 2 | P48023, Q14790 | FASLG, CASP8 | More | | | Pamidronic-acid | hsa05165 | Human papillomavirus infection | 2.62E-02 | 3 | P48023, P04637, Q14790 | FASLG, TP53, CASP8 | More | |
|
